|
Post by JHam on Mar 16, 2015 13:28:18 GMT
|
|
|
Post by natureeguy on Mar 16, 2015 13:45:58 GMT
Wow is right. So, are results like these game changing for the company? Still way too early to tell? The results seem incredible. Trying not to get too excited, but Hoooooray! No question this company is going places.
|
|
|
Post by JHam on Mar 16, 2015 15:03:52 GMT
Wow is right. So, are results like these game changing for the company? Still way too early to tell? The results seem incredible. Trying not to get too excited, but Hoooooray! No question this company is going places. Yeah it is tough to argue with 100% of patients having a complete response AND with no re-occurences. It is only 10 patients so they'll want to prove this in a larger patient set. It almost makes you wonder if this news was partly responsible for the recent big run-up over the past few weeks. Would be nice to know when they first saw the data. Great job for all of you guys holding.
|
|
|
Post by observingthechaos on Apr 21, 2015 15:20:14 GMT
Per the most recent Advaxis presentation, the 3 year recurrence rate for this type of cancer is 45%. The study was opened in April of 2013 and they are reporting these findings in 2015. I find this to be extremely encouraging.
|
|
|
Post by icellman on Apr 22, 2015 11:41:42 GMT
I feel very lucky to have jumped in picking up shares from $ 12.10 to $ 13.50. I think this stock has the potential to get to the 40's. ADXS market cap is 1/4 that of ADRO. They should catch up to ADRO in this regard, which bodes extremely well for ADXS.
|
|
|
Post by iamaverb on Apr 24, 2015 10:55:27 GMT
Here is a good write up and recommendation by Zacks that in my opinion is helping to propel the stock. link
|
|
|
Post by selluwud on Apr 24, 2015 12:03:59 GMT
Does anybody remember this time frame?
|
|
|
Post by iamaverb on Apr 26, 2015 14:39:55 GMT
Does anybody remember this time frame? My first purchase was for $3.32.
|
|